Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Bayer AG | 2,966 |
| 2 | Merck Sharp & Dohme LLC | 2,613 |
| 3 | BASF SE | 2,168 |
| 4 | Bayer CropScience AG | 2,087 |
| 5 | Bristol Myers Squibb Co | 1,977 |
| 6 | Novartis AG | 1,957 |
| 7 | F Hoffmann La Roche AG | 1,718 |
| 8 | Boehringer Ingelheim International GmbH | 1,599 |
| 9 | Bayer Pharma AG | 1,388 |
| 10 | Janssen Pharmaceutica NV | 1,327 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C07D | Heterocyclic compounds | 80,385 |
| 2 | A61P | Therapeutic activity (drug indications) | 72,020 |
| 3 | A61K | Medicinal preparations | 47,479 |
| 4 | C07C | Acyclic and carbocyclic compounds | 19,615 |
| 5 | A01N | Preservation of bodies; biocides; pest repellents | 12,689 |
| 6 | C07F | Organometallic compounds | 8,235 |
| 7 | C07K | Peptides | 5,167 |
| 8 | Y02P | Climate change mitigation: production | 4,258 |
| 9 | C07B | General methods of organic chemistry | 4,095 |
| 10 | C08L | Polymer compositions (blends) | 3,743 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| 1-(BENZO [D] [1,3] DI0X0L-5-YL) -N- (PHENYL) CYCLOPROPANE- CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS FOR THE TREATMENT OF CYSTIC FIBROSIS | 2007 | Vertex Pharmaceuticals Inc | 95 |
| 12, 13-cyclopropane epothilone derivatives | 2002 | Bristol Myers Squibb Co | 62 |
| Substituted cyclopropane carbolic acid(3-methyl-cyclohexyl)amides as taste substances | 2008 | Symrise AG | 52 |
| Poly-[(methylimino)trimethylene] | 1980 | Merck and Co Inc | 52 |
| Partially oriented poly(trimethylene terephthalate) yarn | 2001 | DuPont Industrial Biosciences USA LLC | 50 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Cyclopropane Reaction Mechanisms | 5 |
| 2 | Anesthesia and Neurotoxicity Research | 2 |
| 3 | Anesthesia and Sedative Agents | 2 |
| 4 | Metal complexes synthesis and properties | 2 |
| 5 | Microbial Natural Products and Biosynthesis | 2 |
| 6 | Protein Structure and Dynamics | 2 |
| 7 | Advanced Chemical Physics Studies | 1 |
| 8 | Advanced Chemical Sensor Technologies | 1 |
| 9 | Anesthesia and Pain Management | 1 |
| 10 | Asymmetric Synthesis and Catalysis | 1 |
Technology trend analysis
Cypris uses AI to connect emerging research themes to IP activity, commercialization signals, and underexplored opportunity areas.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Armin de Meijere | University of Göttingen | 12 |
| 2 | Akira Matsuda | Hokkaido University | 10 |
| 3 | Satoshi Shuto | Hokkaido University | 9 |
| 4 | Ana I. Jiménez | Universidad de Zaragoza | 7 |
| 5 | André B. Charette | Université de Montréal | 7 |
| 6 | Antonio M. Echavarren | Institut Català d'Investigació Química | 6 |
| 7 | Michael A. Kerr | Western University | 6 |
| 8 | Min Shi | Shanghai Institute of Organic Chemistry | 6 |
| 9 | Agnieszka Mrozik | University of Silesia in Katowice | 5 |
| 10 | Alfred Burger | 5 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Heterocycles from cyclopropanes: applications in natural product synthesis | 2009 | 889 | Asymmetric Synthesis and Catalysis |
| Olefin Cyclopropanation via Carbene Transfer Catalyzed by Engineered Cytochrome P450 Enzymes | 2012 | 832 | Catalytic C–H Functionalization Methods |
| Cyclopropanation Strategies in Recent Total Syntheses | 2017 | 674 | Asymmetric Synthesis and Catalysis |
| The human gut bacterial genotoxin colibactin alkylates DNA | 2019 | 647 | Gut microbiota and health |
| Biosynthesis and Metabolism of Cyclopropane Rings in Natural Compounds | 2003 | 635 | Asymmetric Synthesis and Catalysis |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition and weight of cyclopropane?
Which organizations hold the most patents involving cyclopropane?
What are the main research topics associated with cyclopropane in the scientific literature?
Who are leading academic researchers publishing on cyclopropane chemistry?
What is the recent patent filing trend for cyclopropane-related inventions?